Healthcare · Biotechnology
Price
$5.70
Market Cap
$329,682
Employees
2
Beta
2.43
Avg Volume
1,083,679
CEO
Oz Adler
Business Description
SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated with Alzheimer's disease; SCI-160, designed to address pain; and SCI-210, targeting autism spectrum disorder and epilepsy. The company has formed strategic alliances to further its goals. A partnership with Procaps focuses on the development and eventual commercial manufacturing of SCI-110, as well as CannAmide, an oral palmitoylethanolamide in a soft gel capsule. SciSparc is also collaborating with the Sheba Fund for Health Services and Research to explore SCI-210's potential in managing status epilepticus. Additionally, it has teamed up with The Israeli Medical Center for Alzheimer's to conduct a Phase IIa clinical trial, evaluating the safety, tolerability, and effectiveness of SCI-110 for patients experiencing Alzheimer's disease and agitation. Founded in 2004, the company initially operated under the name Therapix Biosciences Ltd. before changing to SciSparc Ltd. in January 2021. Its main corporate office is located in Tel Aviv-Yafo, Israel.
Business History
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-0.01
Stock Price: $5.70
EPS (Diluted): -882.64
EPS (Diluted): -882.64
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
39.84
Stock Price: $5.70
Total Equity: $4.24M
Shares: 13,798,333
Total Equity: $4.24M
Shares: 13,798,333
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-13.37
Market Cap: $329,682
Total Debt: $356,000
Cash: $4.59M
EBITDA: -$12.32M
Total Debt: $356,000
Cash: $4.59M
EBITDA: -$12.32M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$164.7M
Market Cap: $329,682
Total Debt: $356,000
Cash: $4.59M
Total Debt: $356,000
Cash: $4.59M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
197.30
Stock Price: $5.70
Revenue: $856,000
Shares: 13,798,333
Revenue: $856,000
Shares: 13,798,333
EV/Sales (Total value vs revenue — works when P/E can't)
API192.37
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
73.7%
Gross Profit: $631,000
Revenue: $856,000
Revenue: $856,000
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-1,022.1%
Operating Income: -$8.75M
Revenue: $856,000
Revenue: $856,000
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-1,422.8%
Net Income: -$12.18M
Revenue: $856,000
Revenue: $856,000
ROE (Profit from shareholder equity)
CALCNet Income / Total Equity
-287.3%
Net Income: -$12.18M
Total Equity: $4.24M
Total Equity: $4.24M
ROIC (Profit from all invested capital)
CALCNOPAT / Invested Capital
-218,725.0%
Operating Income: -$8.75M
Tax Rate: 0.0%
Equity: $4.24M
Total Debt: $356,000
Cash: $4.59M
Tax Rate: 0.0%
Equity: $4.24M
Total Debt: $356,000
Cash: $4.59M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
2.41
Current Assets: $5.44M
Current Liabilities: $2.25M
Current Liabilities: $2.25M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.08
Short-Term Debt: $356,000
Long-Term Debt: $0.00
Total Debt: $356,000
Total Equity: $4.24M
Long-Term Debt: $0.00
Total Debt: $356,000
Total Equity: $4.24M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$0.06
Revenue: $856,000
Shares: 13,798,333
Shares: 13,798,333
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$0.31
Total Equity: $4.24M
Shares: 13,798,333
Shares: 13,798,333
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.30
Operating CF: -$4.14M
CapEx: $0.00
Shares: 13,798,333
CapEx: $0.00
Shares: 13,798,333
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $5.70
Stock Price: $5.70
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$12.18M
Net Income: -$12.18M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares SPRC against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 26, 2026 1:16am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.1M | $1.3M | $2.9M | $1.3M | $856,000 |
| Cost of Revenue | $33,000 | $322,000 | $683,000 | $800,000 | $225,000 |
| Gross Profit | $1.0M | $1.0M | $2.2M | $506,000 | $631,000 |
| Operating Expenses | $5.8M | $8.4M | $8.0M | $7.8M | $9.4M |
| Operating Income | -$5.8M | -$7.4M | -$5.8M | -$7.3M | -$8.7M |
| Net Income | -$5.8M | -$2.6M | -$5.1M | -$6.3M | -$12.2M |
| EBITDA | -$5.7M | -$2.4M | -$5.3M | -$7.0M | -$12.3M |
| EPS | $-659.52 | $-132.57 | $-112.95 | $-9.72 | $-882.64 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 26, 2026 1:16am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $6.9M | $3.6M | $2.1M | $1.5M | $4.6M |
| Total Current Assets | $9.8M | $4.5M | $6.4M | $7.5M | $5.4M |
| Total Assets | $9.9M | $10.6M | $11.2M | $10.3M | $7.6M |
| Current Liabilities | $1.8M | $4.2M | $1.6M | $1.4M | $2.3M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.8M | $4.2M | $1.6M | $1.4M | $2.5M |
| Total Equity | $8.1M | $6.4M | $7.6M | $8.2M | $4.2M |
| Retained Earnings | -$61.0M | -$63.6M | -$68.7M | -$75.0M | -$87.2M |
Cash Flow (Annual)
Last updated: Jun 26, 2026 1:16am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$5.1M | -$7.9M | -$5.9M | -$5.1M | -$4.1M |
| Capital Expenditure | $-35,000 | -$4.9M | $0 | $0 | $0 |
| Free Cash Flow | -$5.1M | -$12.8M | -$5.9M | -$5.1M | -$4.1M |
| Acquisitions (net) | $0 | $-700,000 | $2.6M | $-600,000 | $600,000 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $4.9M | -$3.3M | -$1.5M | $-536,000 | $3.1M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 12:59am (8h ago)| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue |
$6.3B $6.3B – $6.3B
|
$7.0B $7.0B – $7.0B
|
$6.6B $6.6B – $6.6B
|
| EBITDA |
-$6.3B -$6.3B – -$6.3B
|
-$7.0B -$7.0B – -$7.0B
|
-$6.6B -$6.6B – -$6.6B
|
| Net Income |
$146,614 $146,614 – $146,614
|
$419,193 $419,193 – $419,193
|
$459,484 $459,484 – $459,484
|
| EPS | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 26, 2026 1:16am (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +26.0% | +113.7% | -54.6% | -34.5% |
| Gross Profit Growth | -1.1% | +114.2% | -77.0% | +24.7% |
| Operating Income Growth | -27.9% | +21.8% | -26.7% | -19.6% |
| Net Income Growth | +55.3% | -97.6% | -22.7% | -93.8% |
| EBITDA Growth | +59.0% | -125.6% | -31.2% | -76.6% |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for SPRC — it's generated by the pipeline (
market-narrative step).
No community reviews yet for SPRC.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30